NCT03097276

Brief Summary

Anastomotic fistula is the most feared complication after surgical resection of colorectal cancer (CCR). It occurs in 6 to 15% of patients. Beyond the risk of death in the immediate postoperative period, the pain that it induces, the resources required for its management, the need for stomata with a negative impact on patients' quality of life and the prolongation of hospitalization, it also has a now-recognized adverse effect on long-term survival. The early detection of this complication may limit its impact. C-reactive protein (CRP) has proved to be an early, reliable marker of the onset of infectious complications of colorectal surgery. However, the diagnostic procedure to implement in these patients is not at all codified, since this population concerned by systematic CRP assay in the postoperative period is very recent. The procedures to implement in these patients so that they can obtain the maximal benefit of an early diagnosis have not yet been established. An algorithm for the proactive clinical management must be drawn up to be able to confirm or rule out the presence of a fistula as soon as a high level of CRP is detected, and to propose a quick treatment to ensure that patients benefit from this early diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 31, 2017

Completed
17 days until next milestone

Study Start

First participant enrolled

April 17, 2017

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2021

Completed
Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

4.5 years

First QC Date

March 27, 2017

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • proportion of patients with total hospitalization of less than 15 days during the first postoperative month

    45 days

Study Arms (1)

Patients who underwent open decompression surgery

OTHER
Procedure: blood sampleRadiation: CT scan

Interventions

blood samplePROCEDURE

blood sample will be collected

Patients who underwent open decompression surgery
CT scanRADIATION

CT scan

Patients who underwent open decompression surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 18 and older,
  • with a CRP level \> 140 mg/L at D3 or CRP \> 125 mg/L at D4 following colon and/or rectal resection with anastomosis (protected or not by an upstream stoma)
  • without clinical signs of severe peritonitis (fever, severe sepsis, generalized abdominal contracture)
  • who have provided written informed consent.

You may not qualify if:

  • patients who have undergone intraperitoneal chemotherapy in the context of the surgical treatment for peritoneal carcinomatosis
  • patients with a diagnosis of another infection that could explain the high CRP level,
  • patients who underwent eventration repair at the time of the colorectal resection
  • patients with an obvious indication for revisit surgery
  • persons without health insurance cover
  • adults under guardianship
  • pregnant or beast-feeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Dijon

Dijon, 21079, France

Location

Related Publications (1)

  • Gozalichvili D, Fournel I, Sow AK, Guiraud A, Moreno-Lopez N, Orry D, Facy O, Ortega-Deballon P. Management of patients with high C-reactive protein levels after elective colorectal surgery: Pilot study on a proactive diagnostic and therapeutic approach (GESPACE). J Visc Surg. 2024 Aug;161(4):237-243. doi: 10.1016/j.jviscsurg.2024.06.002. Epub 2024 Jun 21.

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2017

First Posted

March 31, 2017

Study Start

April 17, 2017

Primary Completion

October 1, 2021

Study Completion

December 15, 2021

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations